These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 35781252)

  • 41. Cellular mechanisms for trazodone-induced cardiotoxicity.
    Lee S; Lee HA; Kim SJ; Kim KS
    Hum Exp Toxicol; 2016 May; 35(5):501-10. PubMed ID: 26187900
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Assessment of drug-induced arrhythmic risk using limit cycle and autocorrelation analysis of human iPSC-cardiomyocyte contractility.
    Kirby RJ; Qi F; Phatak S; Smith LH; Malany S
    Toxicol Appl Pharmacol; 2016 Aug; 305():250-258. PubMed ID: 27343406
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Screening for acute IKr block is insufficient to detect torsades de pointes liability: role of late sodium current.
    Yang T; Chun YW; Stroud DM; Mosley JD; Knollmann BC; Hong C; Roden DM
    Circulation; 2014 Jul; 130(3):224-34. PubMed ID: 24895457
    [TBL] [Abstract][Full Text] [Related]  

  • 44. How in vitro influences in silico utilized for the prediction of in vivo - pilot study of the drug-induced pro-arrhythmic potency prediction.
    Badyra B; Lisowski B; Polak S; Kudolo J; Wiśniowska B
    Folia Med Cracov; 2015; 55(4):5-19. PubMed ID: 26867116
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A Preclinical Study on Brugada Syndrome with a CACNB2 Variant Using Human Cardiomyocytes from Induced Pluripotent Stem Cells.
    Zhong R; Schimanski T; Zhang F; Lan H; Hohn A; Xu Q; Huang M; Liao Z; Qiao L; Yang Z; Li Y; Zhao Z; Li X; Rose L; Albers S; Maywald L; Müller J; Dinkel H; Saguner A; Janssen JWG; Swamy N; Xi Y; Lang S; Kleinsorge M; Duru F; Zhou X; Diecke S; Cyganek L; Akin I; El-Battrawy I
    Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35955449
    [TBL] [Abstract][Full Text] [Related]  

  • 46. An impedance-based approach using human iPSC-derived cardiomyocytes significantly improves in vitro prediction of in vivo cardiotox liabilities.
    Koci B; Luerman G; Duenbostell A; Kettenhofen R; Bohlen H; Coyle L; Knight B; Ku W; Volberg W; Woska JR; Brown MP
    Toxicol Appl Pharmacol; 2017 Aug; 329():121-127. PubMed ID: 28546047
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effects of ambasilide, quinidine, flecainide and verapamil on ultra-rapid delayed rectifier potassium currents in canine atrial myocytes.
    Yue L; Feng JL; Wang Z; Nattel S
    Cardiovasc Res; 2000 Apr; 46(1):151-61. PubMed ID: 10727663
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Yohimbine Directly Induces Cardiotoxicity on Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes.
    Gong Y; Yang L; Tang J; Zheng J; Witman N; Jakob P; Tan Y; Liu M; Chen Y; Wang H; Fu W; Wang W
    Cardiovasc Toxicol; 2022 Feb; 22(2):141-151. PubMed ID: 34817810
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Automated Dynamic Clamp for Simulation of I
    Becker N; Horváth A; De Boer T; Fabbri A; Grad C; Fertig N; George M; Obergrussberger A
    Curr Protoc Pharmacol; 2020 Mar; 88(1):e70. PubMed ID: 31868992
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The Use of Ratiometric Fluorescence Measurements of the Voltage Sensitive Dye Di-4-ANEPPS to Examine Action Potential Characteristics and Drug Effects on Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes.
    Hortigon-Vinagre MP; Zamora V; Burton FL; Green J; Gintant GA; Smith GL
    Toxicol Sci; 2016 Dec; 154(2):320-331. PubMed ID: 27621282
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The Use of Voltage Sensitive Dye di-4-ANEPPS and Video-Based Contractility Measurements to Assess Drug Effects on Excitation-Contraction Coupling in Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes.
    Hortigon-Vinagre MP; Zamora V; Burton FL; Smith GL
    J Cardiovasc Pharmacol; 2021 Mar; 77(3):280-290. PubMed ID: 33109927
    [TBL] [Abstract][Full Text] [Related]  

  • 52. In silico screening of the impact of hERG channel kinetic abnormalities on channel block and susceptibility to acquired long QT syndrome.
    Romero L; Trenor B; Yang PC; Saiz J; Clancy CE
    J Mol Cell Cardiol; 2014 Jul; 72():126-37. PubMed ID: 24631769
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Electrophysiological characterization of cardiomyocytes derived from human induced pluripotent stem cells.
    Honda M; Kiyokawa J; Tabo M; Inoue T
    J Pharmacol Sci; 2011; 117(3):149-59. PubMed ID: 22027094
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Deep learning detects cardiotoxicity in a high-content screen with induced pluripotent stem cell-derived cardiomyocytes.
    Grafton F; Ho J; Ranjbarvaziri S; Farshidfar F; Budan A; Steltzer S; Maddah M; Loewke KE; Green K; Patel S; Hoey T; Mandegar MA
    Elife; 2021 Aug; 10():. PubMed ID: 34338636
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Assessment of Drug Proarrhythmic Potential in Electrically Paced Human Induced Pluripotent Stem Cell-Derived Ventricular Cardiomyocytes Using Multielectrode Array.
    Bai S; Pei J; Chen K; Zhao Y; Cao H; Tian L; Ma Y; Dong H
    SLAS Discov; 2021 Mar; 26(3):364-372. PubMed ID: 32914673
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A computational model of induced pluripotent stem-cell derived cardiomyocytes incorporating experimental variability from multiple data sources.
    Kernik DC; Morotti S; Wu H; Garg P; Duff HJ; Kurokawa J; Jalife J; Wu JC; Grandi E; Clancy CE
    J Physiol; 2019 Sep; 597(17):4533-4564. PubMed ID: 31278749
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Modulation of the heart's electrical properties by the anticonvulsant drug retigabine.
    Rubi L; Kovar M; Zebedin-Brandl E; Koenig X; Dominguez-Rodriguez M; Todt H; Kubista H; Boehm S; Hilber K
    Toxicol Appl Pharmacol; 2017 Aug; 329():309-317. PubMed ID: 28641963
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Drug-induced shortening of the electromechanical window is an effective biomarker for in silico prediction of clinical risk of arrhythmias.
    Passini E; Trovato C; Morissette P; Sannajust F; Bueno-Orovio A; Rodriguez B
    Br J Pharmacol; 2019 Oct; 176(19):3819-3833. PubMed ID: 31271649
    [TBL] [Abstract][Full Text] [Related]  

  • 59. New
    An JR; Mun SY; Jung IK; Kim KS; Kwon CH; Choi SO; Park WS
    Korean J Physiol Pharmacol; 2023 May; 27(3):267-275. PubMed ID: 37078300
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Moving beyond the comprehensive in vitro proarrhythmia assay: Use of human-induced pluripotent stem cell-derived cardiomyocytes to assess contractile effects associated with drug-induced structural cardiotoxicity.
    Yang X; Papoian T
    J Appl Toxicol; 2018 Sep; 38(9):1166-1176. PubMed ID: 29484688
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.